Tocagen logo — company profile

Tocagen

Founded 2007 10 employees Post-IPO Equity Total: $198.61M Biopharma, Biotechnology +1

General Information

Company Name Tocagen
Founded Year 2007
Founders / Decision Makers
Team member Team member
Employees 10
Industries Biopharma, Biotechnology, Health and Wellness
Funding Stage Post-IPO Equity
Social

BounceWatch is an independent company data service, not affiliated with Tocagen. To contact Tocagen, visit tocagen.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Tocagen compare?

A PDF of Tocagen and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Tocagen soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Tocagen

Tocagen is a biopharmaceutical company founded in 2007 with a mission to develop first-in-class, broadly applicable product candidates designed to activate a patient’s immune system against their own cancer from within. The company secured a $30.00M post-IPO equity investment on 12 December 2018, reflecting the confidence of investors in their innovative approach to cancer treatment. Tocagen operates within the biopharma, biotechnology, health, and wellness industries, making them a significant player in the global effort to tackle cancer.

Funding Rounds & Investors (12)

View All
Funding Stage Amount Investors Lead Investors Date
Post IPO Equity $30.00M -
12 Dec 2018
Post IPO Equity $72.50M 1
Whiz Partners
20 Apr 2017
Venture Round $28.80M -
10 Aug 2015
Venture Round $210.00K -
20 May 2013
Venture Round $9.06M -
05 Dec 2012
Venture Round $15.31M -
08 Nov 2011
Venture Round $5.27M -
05 Oct 2010
Series D $7.80M -
09 Mar 2010
Series C $3.00M -
26 Feb 2010
Series C $9.12M -
23 Nov 2009

View All 12 Funding Rounds

Tocagen Alternatives & Competitors

View All Alternatives
Tocagen vs
IO Biotech
IO Biotech Denmark

Break Boundaries. Ignite Change.

Post-IPO Equity
91 employees
Biotechnology, Health Care
Tocagen vs
Onchilles Pharma
Onchilles Pharma United States

Developing drug candidates that have the potential to be broadly effective against a wide range of c...

Series B
10 employees
Biopharma, Biotechnology
Tocagen vs

Northwest Biotherapeutics, Inc. is a development stage biotechnology company focused on discovering,...

Post-IPO Debt
16 employees
Biotechnology, Health Care

FAQ About Tocagen

Driven by our vision, as a fully integrated global biotech company,our mission is to develop first-in-class, broadly applicable, product candidates that are designed to activate a patient’s immune system against their own cancer from within.
Tocagen was founded in 2007.
Tocagen operates in Biopharma, Biotechnology and Health and Wellness.
Tocagen has approximately 10 employees.
Tocagen has completed 12 funding rounds, raising a total of $198.61M. The latest funding stage is Post-IPO Equity.
Top alternatives and competitors to Tocagen include IO Biotech, Onchilles Pharma, Northwest Biotherapeutics, Normunity, Aulos Bioscience. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Tocagen and IO Biotech are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Tocagen, https://bouncewatch.com/company/tocagen, updated 14 January 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes